Format

Send to

Choose Destination
See comment in PubMed Commons below
Future Oncol. 2011 Jun;7(6):727-36. doi: 10.2217/fon.11.49.

Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.

Author information

1
Mount Vernon Cancer Centre, Northwood, Middlesex HA6 2RN, UK.

Abstract

Metformin is an orally available, biguanide derivative that is widely used in the treatment of Type 2 diabetes. Recent preclinical data have demonstrated that it can also act as an anticancer agent by activation of AMPK and subsequent inhibition of mTOR. Metformin is currently being investigated in several Phase II/III clinical trials. This article will review the current evidence for its mechanism of action, efficacy in preclinical and clinical models, and toxicity. Ongoing and planned studies evaluating the impact of metformin on breast cancer outcomes are also discussed.

PMID:
21675836
DOI:
10.2217/fon.11.49
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center